Table 1.

Historical NIH funding levels for HIV/AIDS research.

Therapeutics Funding Metric	Funding Year					Single-Year Peak
	1984	1994	2004	2014	2018	Year	Amount
Total HIV/AIDS Funding‡	$104M†	$2.1B	$3.7B	$3.1B	$2.9B	2004	$3.69B
Therapeutics Funding (TF)	$18M	$768M	$945M	$762M	$352M	2003	$967M
TF as a % of the Total NIH HIV/AIDS Budget	17%	36%	26%	25%	12%	1987	46.8%
No. Drugs Approved (Cumulative 1984-year)	0	4	26	40	55	2018	8

^†All funding presented in 2017 dollars. Note that a change in programmatic funding reporting led to a substantial reduction in funds reported for HIV therapeutics development from 2017 onward [12,13].

^‡Total funding includes allocations for the following research categories in addition to Therapeutics: Vaccines, HIV Microbicides, Behavioral and Social Science, Etiology and Pathogenesis, Natural History and Epidemiology, Training, Infrastructure, and Capacity Building, and Information Dissemination.